Log-in
E-Mail
Passwort
Merken
Passwort vergessen?
Werden Sie kostenlos Mitglied
Registrieren
Registrieren
Neukunde
Unser Angebot
Einstellungen
Einstellungen
Dynamische Kurse 
OFFON

4-Traders Homepage  >  Aktien  >  Euronext Paris  >  Guerbet    GBT   FR0000032526

GUERBET (GBT)
Mes dernières consult.
Populärste Aktien
  Report  
ÜbersichtKurseChartsNewsAnalysenTermineUnternehmenFundamentaldatenAnalystenschätzungenRevisionen 
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
Kurzporträt
Logo Guerbet
Engages in research, development and production of X-Rays and its by products

Guerbet SA engages in the research, development, manufacture, and sale of contrast products for medical imaging.

The company products portfolio includes diagnostic imaging, and interventional imaging.

It operates through the following segments: Magnetic Resonance Imaging, X-ray Imaging, Interventional Radiology & Theranostics, and Imaging Solutions & Services.

The company was founded by André Guerbet on July 16, 1926 and is headquartered in Paris, France.

Mitarbeiteranzahl : 2 762 Personen.
Verkäufe nach Geschäftsbereichen
20162017Delta
EUR (in Millionen)%EUR (in Millionen)%
X- Rays375,4748.4%376,1246.6% +0.17%
MRI246,7031.8%272,0033.7% +10.26%
SIS76,809.9%79,909.9% +4.04%
RIT55,867.2%56,507% +1.15%
Other21,722.8%22,602.8% +4.04%
Verkäufe nach Regionen
20162017Delta
EUR (in Millionen)%EUR (in Millionen)%
Other Markets402,9351.9%432,4153.6% +7.32%
Europe372,8548.1%374,7146.4% +0.5%
Vorstände
Name AlterSeitTitel
Yves L'Epine, MD592011Chief Executive Officer & Non-Independent Director
Marie-Claire Janailhac-Fritsch632011Chairman
Jean-François Le Martret--Chief Financial Officer
Claire Corot--Senior Vice President-Research & Innovation
Pierre Desche--SVP-Development, Medical & Regulatory Affairs
Jean-François Blanc--Vice President-Technical Operations
Marion Barbier602011Non-Independent Director
Claire Massiot-Jouault572013Non-Independent Director
Mark Fouquet592014Non-Independent Director
Didier Izabel632014Independent Director
Aktien
Vote MengeFloatKonzerneigene AktienTotal Float
Aktie A 1 12 563 358 5 269 464 41.9% 20 428 0.2% 41.9%
Aktionäre
NameAktien%
Guerbet Family 7 004 209 55,8%
Norges Bank Investment Management 360 911 2,87%
Oddo BHF Asset Management SAS 355 313 2,83%
Amundi Asset Management SA (Investment Management) 161 199 1,28%
The Vanguard Group, Inc. 113 102 0,90%
Dimensional Fund Advisors LP 109 642 0,87%
Wasatch Advisors, Inc. 100 000 0,80%
Ennismore Fund Management Ltd. 94 957 0,76%
Amplegest SAS 90 206 0,72%
Financière de l'Échiquier SA 78 065 0,62%
Holdings
NameAktien%Wert
Guerbet (GBT) 19 4280,15%1 242 771 USD
Börsenplätze und Indizes
- Eligible PEA / SRD : JA / JA
- Euronext Paris
- Compartiment B
- CAC All Shares / CAC All-Tradable, CAC Mid Small, CAC PME, CAC Small, EnterNext© PEA-PME 150, PEA, PEA-PME
Börsen Codes
- Bloomberg Code :  GBT:FP
- Reuters Code :  GRBT.PA
- Datastream Code :  F:GUER
Unternehmenskontakt
Guerbet
15 rue des Vanesses
FR-93420 Villepinte
Frankreich

Telefon : +33 (0)1 45 91 50 00
Fax : +33 (0)1 45 91 51 99
Internet : http://www.guerbet.com
Branche Diagnostic & Testing Substances Manufacturers
01.01.Marktkap. (M$)
GUERBET-29.26%819
JOHNSON & JOHNSON-12.25%328 858
PFIZER0.39%212 690
NOVARTIS-8.25%193 330
ROCHE HOLDING LTD.-14.81%184 168
MERCK AND COMPANY8.39%166 880
ABBVIE2.96%158 006
AMGEN6.39%122 422
ABBOTT LABORATORIES10.23%110 293
BAYER-2.22%108 112
GLAXOSMITHKLINE17.41%102 311
SANOFI-4.41%99 713
ELI LILLY AND COMPANY2.87%94 302
ASTRAZENECA5.12%90 821
BRISTOL-MYERS SQUIBB COMPANY-10.57%89 573
NOVO NORDISK A/S-14.25%85 281
BIOGEN-9.24%64 364
CSL LIMITED30.59%62 107
ALLERGAN PLC5.87%58 719
CELGENE CORPORATION-25.18%56 595
SHIRE3.53%49 016
Verbindungen : Guerbet
Calenzane SAS
Mgf Easybike SAS
ABAREM
Abalux
Institut Français Des Administrateurs
LMP SARL
Bird & Bird LLP
Terranere SAS
Paris Bar Association
Xelos SAS
Association Des Médiateurs Européens
MGF SAS
La Residence de la Ferme De Croisil
Axys Finance SARL
Simpl-Fi SARL
Financière Des Pins SARL
© 2018 People , Fundamentals and Ownership    © 2018 Cofisem